GlobeNewsWire · GLP · October 16, 2026

Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Get the app for more

Explore stock news, insights and company research.